JP2013503880A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503880A5
JP2013503880A5 JP2012528002A JP2012528002A JP2013503880A5 JP 2013503880 A5 JP2013503880 A5 JP 2013503880A5 JP 2012528002 A JP2012528002 A JP 2012528002A JP 2012528002 A JP2012528002 A JP 2012528002A JP 2013503880 A5 JP2013503880 A5 JP 2013503880A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
pharmaceutical composition
group
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012528002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503880A (ja
JP5653438B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/047488 external-priority patent/WO2011028775A1/en
Publication of JP2013503880A publication Critical patent/JP2013503880A/ja
Publication of JP2013503880A5 publication Critical patent/JP2013503880A5/ja
Application granted granted Critical
Publication of JP5653438B2 publication Critical patent/JP5653438B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012528002A 2009-09-04 2010-09-01 オルトミクソウイルス感染の治療方法 Expired - Fee Related JP5653438B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US27225409P 2009-09-04 2009-09-04
US61/272,254 2009-09-04
US28250810P 2010-02-22 2010-02-22
US61/282,508 2010-02-22
US35393510P 2010-06-11 2010-06-11
US61/353,935 2010-06-11
PCT/US2010/047488 WO2011028775A1 (en) 2009-09-04 2010-09-01 Methods of treating orthomyxoviral infections

Publications (3)

Publication Number Publication Date
JP2013503880A JP2013503880A (ja) 2013-02-04
JP2013503880A5 true JP2013503880A5 (https=) 2014-03-20
JP5653438B2 JP5653438B2 (ja) 2015-01-14

Family

ID=43649616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528002A Expired - Fee Related JP5653438B2 (ja) 2009-09-04 2010-09-01 オルトミクソウイルス感染の治療方法

Country Status (12)

Country Link
US (2) US20110065752A1 (https=)
EP (1) EP2473482B1 (https=)
JP (1) JP5653438B2 (https=)
KR (1) KR101497194B1 (https=)
CN (1) CN102625796B (https=)
BR (1) BR112012004676A2 (https=)
CA (1) CA2772875A1 (https=)
DK (1) DK2473482T3 (https=)
ES (1) ES2466027T3 (https=)
MX (1) MX2012002486A (https=)
PL (1) PL2473482T3 (https=)
WO (1) WO2011028775A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2398321B1 (en) 2009-02-23 2015-11-25 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
KR20150035767A (ko) 2012-06-06 2015-04-07 유니터 바이롤로지, 엘엘씨 신규 이미노당 및 그의 용도
JP6456393B2 (ja) 2013-09-16 2019-01-23 エマージェント バイロロジー エルエルシー デオキシノジリマイシン誘導体およびその使用方法
BR112017008898B1 (pt) 2014-11-05 2022-11-29 Emergent Virology Llc Compostos de iminoaçúcares, suas composições farmacêuticas e usos dos mesmos para tratar doenças virais
WO2017201030A1 (en) * 2016-05-16 2017-11-23 Emergent Virology Llc Methods of treating viral infection
US20220257604A1 (en) * 2019-03-08 2022-08-18 University Of Virginia Patent Foundation Compositions and methods for modulating viral infections by regulating glucosylceramides
CN111904959A (zh) * 2020-08-21 2020-11-10 牡丹江医学院 α-L-岩藻糖苷酶抑制剂在制备治疗小儿肺炎的药物中的用途
IT202200007808A1 (it) * 2022-04-20 2023-10-20 Luigi Michele Pavone Composizioni terapeutiche per malattie causate da accumulo di eparan solfato
CN119841765B (zh) * 2025-01-09 2025-10-10 中南大学 Dnj衍生物、药物组合物及其应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8013A (en) * 1851-04-01 Improvement in wheat-fans
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
KR20010033028A (ko) * 1997-12-11 2001-04-25 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 막-관련 바이러스 복제의 억제
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
EP1196190B1 (en) * 1999-07-26 2003-03-19 G.D. SEARLE & CO. Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
ES2302697T3 (es) * 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales.
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
EP2857036B1 (en) * 2003-01-31 2016-12-21 Mount Sinai School of Medicine of New York University Combination therapy for treating protein deficiency disorders
US7446098B2 (en) * 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
CA2601797A1 (en) * 2005-03-16 2006-09-21 University Of Oxford Mannose immunogens for hiv-1
EP3782655A1 (en) * 2005-05-17 2021-02-24 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
KR20080031474A (ko) * 2005-07-27 2008-04-08 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 안구 질환의 치료를 위한 열충격의 사용
US20100004156A1 (en) * 2005-07-27 2010-01-07 Shalesh Kaushal Small Compounds That Correct Protein Misfolding and Uses Thereof
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
DE602007008870D1 (de) * 2006-04-24 2010-10-14 Amc Amsterdam Verbessertes verfahren zur behandlung von cystischer fibrose
CN104876855A (zh) * 2006-05-24 2015-09-02 联合治疗公司 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
KR20090057035A (ko) * 2006-08-21 2009-06-03 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 치료를 위한 병용 요법
CN101172127B (zh) * 2006-10-31 2011-12-07 上海市新文达生物科技有限公司 一种桑叶提取物及其在制备抗甲型流感病毒药物中的应用
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
CN101278977B (zh) * 2008-03-31 2012-05-30 广州唐百服生物科技有限公司 一种桑叶主要活性成分的提取方法及其提取物用途

Similar Documents

Publication Publication Date Title
JP2013503880A5 (https=)
CN110325187B (zh) N-氨基甲酰亚胺基-5-(1-甲基-1h-吡唑-4-基)-2-萘甲酰胺在制备治疗流感的药物中的用途
JP2017531038A5 (https=)
JP2009535352A5 (https=)
JP2014500861A5 (https=)
JP2013503881A5 (https=)
JP2009501732A5 (https=)
JP2014515351A5 (https=)
JP2013537423A5 (https=)
JP2013516450A5 (https=)
JP2018021051A5 (https=)
JP2009504763A5 (https=)
JP2010501584A5 (https=)
CN113304166B (zh) 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途
EA201201031A1 (ru) Ингибиторы вируса гепатита с
JP2012518649A5 (https=)
JP2009536660A5 (https=)
WO2012018534A3 (en) Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
NZ598208A (en) Inhibitors of flaviviridae viruses
EP2120952A2 (en) Antiviral compounds and methods of using thereof
JP2014526554A5 (https=)
JP2013503882A5 (https=)
RU2016111704A (ru) Производные дезоксинойиримицина и способы их применения
JP2013542981A5 (https=)
JP5653438B2 (ja) オルトミクソウイルス感染の治療方法